HK1063795A1 - Process for the production of the piperidine derivative fexofenadine - Google Patents

Process for the production of the piperidine derivative fexofenadine

Info

Publication number
HK1063795A1
HK1063795A1 HK04106643A HK04106643A HK1063795A1 HK 1063795 A1 HK1063795 A1 HK 1063795A1 HK 04106643 A HK04106643 A HK 04106643A HK 04106643 A HK04106643 A HK 04106643A HK 1063795 A1 HK1063795 A1 HK 1063795A1
Authority
HK
Hong Kong
Prior art keywords
fexofenadine
production
piperidine derivative
piperidine
derivative
Prior art date
Application number
HK04106643A
Other languages
English (en)
Inventor
Collin Schroeder
Ryan Huddleston
Richard Charles
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of HK1063795A1 publication Critical patent/HK1063795A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK04106643A 2001-06-15 2004-09-03 Process for the production of the piperidine derivative fexofenadine HK1063795A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29839701P 2001-06-15 2001-06-15
PCT/EP2002/006424 WO2002102776A1 (en) 2001-06-15 2002-06-12 Process for the production of the piperidine derivative fexofenadine

Publications (1)

Publication Number Publication Date
HK1063795A1 true HK1063795A1 (en) 2005-01-14

Family

ID=23150325

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04106643A HK1063795A1 (en) 2001-06-15 2004-09-03 Process for the production of the piperidine derivative fexofenadine

Country Status (23)

Country Link
US (2) US6743941B2 (pt)
EP (1) EP1401816B1 (pt)
JP (1) JP4344230B2 (pt)
KR (1) KR100903285B1 (pt)
CN (1) CN1229347C (pt)
AR (1) AR037005A1 (pt)
AT (1) ATE386021T1 (pt)
AU (1) AU2002320847B2 (pt)
BR (1) BR0210410A (pt)
CA (1) CA2450313C (pt)
DE (1) DE60225008T2 (pt)
DK (1) DK1401816T3 (pt)
ES (1) ES2298384T3 (pt)
HK (1) HK1063795A1 (pt)
HU (1) HUP0401125A2 (pt)
IL (2) IL159304A0 (pt)
MX (1) MXPA03010960A (pt)
NO (1) NO20035572L (pt)
NZ (1) NZ530153A (pt)
PL (1) PL364369A1 (pt)
PT (1) PT1401816E (pt)
WO (1) WO2002102776A1 (pt)
ZA (1) ZA200308697B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
CN100453522C (zh) * 2005-01-26 2009-01-21 中国科学技术大学 4-[4-(1-乙氧基酰基-1-甲基乙基苯)]-4-氧代丁酸的制备方法
WO2007135693A2 (en) * 2006-05-18 2007-11-29 Ind-Swift Laboratories Limited Intermediates useful for the preparation of antihistaminic piperidine derivative
ITMI20061491A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
CN102070490B (zh) * 2009-11-21 2014-07-30 浙江华海药业股份有限公司 一种非索非那定中间体2-(4-(4-羟基丁酰基)苯基)-2-甲基丙氰的制备方法
CN102070570A (zh) * 2009-11-21 2011-05-25 浙江华海药业股份有限公司 一种非索非那定中间体2-甲基-2(4-(2-氧代四氢呋喃-3-羰基)苯基)丙氰及其盐的制备方法
EP3842429B1 (en) 2015-06-15 2022-09-07 Asana BioSciences, LLC Heterocyclic inhibitors of erk1 and erk2 and their use in the treatment of cancer
CN104876853B (zh) * 2015-06-17 2017-06-16 苏州卫生职业技术学院 盐酸非索非那定的合成方法
WO2017068129A1 (en) 2015-10-22 2017-04-27 Sanofi-Aventis Deutschland Gmbh Process for the preparation of fexofenadine and of intermediates used therein
US20230027072A1 (en) 2019-10-28 2023-01-26 Asana Biosciences, Llc Improved methods, kits, compositions and dosing regimens for the use of heterocyclic inhibitors of erk1 and erk2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2946809A1 (de) * 1979-11-20 1981-06-11 A. Nattermann & Cie GmbH, 5000 Köln 4-phenyl-4-oxo-buttersaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende arzneimittel
IT1200123B (it) 1985-09-27 1989-01-05 Ind Chimica Srl Procedimento per la preparazione di alfa-(p-terbutilfenil)-4-(idrossidifenilmetil)-1-piperidinobutanolo
EP0347123A3 (en) 1988-06-17 1991-07-03 Fisons Corporation Dibenzo-cycloheptenyl, -cycloheptyl and -oxepinyl amines having antihistaminic properties
IT1249684B (it) 1991-07-19 1995-03-09 Sorin Biomedica Spa Epitopi della proteina env del virus dell'epatite c.
WO1993021156A1 (en) * 1992-04-10 1993-10-28 Merrell Dow Pharmaceuticals Inc. 4-diphenylmethyl piperidine derivatives and process for their preparation
DE69415319T2 (de) 1993-06-24 1999-06-10 Albany Molecular Research, Inc., Albany, N.Y. Verfahren zur herstellung von piperidinderivaten

Also Published As

Publication number Publication date
ZA200308697B (en) 2004-09-03
JP2005502603A (ja) 2005-01-27
HUP0401125A2 (hu) 2004-09-28
ES2298384T3 (es) 2008-05-16
PL364369A1 (en) 2004-12-13
DE60225008D1 (de) 2008-03-27
NZ530153A (en) 2005-07-29
NO20035572L (no) 2004-02-16
IL159304A0 (en) 2004-06-01
EP1401816B1 (en) 2008-02-13
US20040198983A1 (en) 2004-10-07
DE60225008T2 (de) 2009-01-29
DK1401816T3 (da) 2008-06-09
AU2002320847B2 (en) 2007-09-20
BR0210410A (pt) 2004-08-17
ATE386021T1 (de) 2008-03-15
WO2002102776A1 (en) 2002-12-27
US7235665B2 (en) 2007-06-26
EP1401816A1 (en) 2004-03-31
CN1229347C (zh) 2005-11-30
JP4344230B2 (ja) 2009-10-14
US6743941B2 (en) 2004-06-01
NO20035572D0 (no) 2003-12-12
KR20040010720A (ko) 2004-01-31
PT1401816E (pt) 2008-04-08
AR037005A1 (es) 2004-10-20
CN1516689A (zh) 2004-07-28
MXPA03010960A (es) 2004-02-27
US20030105329A1 (en) 2003-06-05
IL159304A (en) 2010-02-17
CA2450313C (en) 2010-08-10
KR100903285B1 (ko) 2009-06-17
CA2450313A1 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
IL195011A0 (en) Process for preparing piperidine derivatives
AU2003284371A8 (en) Improved ethanol production process
EP1471045A4 (en) PROCESS FOR PRODUCING FLUORENE DERIVATIVE
GB0129611D0 (en) Process for production of styrene
HK1063795A1 (en) Process for the production of the piperidine derivative fexofenadine
GB2381524B (en) Process for the production of xylitol
HUP0303179A3 (en) A process for the production of aromatic vinegar
HRP20040161A2 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
IL154803A0 (en) New process for the production of oxabispidines
HUP0200567A3 (en) Process for the fermentative production of o-acetyl-serin
MXPA03009806A (es) Derivados de piperazino y su uso como inhibidor de fosfodiesterasa de nucleotido ciclico de tipo 4 (pde4).
IL148376A0 (en) A method for the production of pure silica
IL158998A0 (en) Process for the production of 4-amino-2, 5-bisheterocyclylquinazolines
HUP0301652A3 (en) Process for the production of piperidine derivatives with microorganisms
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
ZA200501601B (en) Process for producing indolopyrrolocarbazole derivative
HK1080076A1 (zh) 喹諾酮羧酸衍生物的製備方法
HUP0105482A2 (en) Process for the production of paroxetine
AU2003231469A8 (en) Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
PL366768A1 (en) Method for the production of improved pulp
HK1060369A1 (en) Process for production of polypeptides
IL151253A0 (en) Process for production of highly pure donepezil hydrochloride
IL158119A0 (en) Method for the production of delta1-pyrrolines
SG106144A1 (en) Process for the production of phosphonium phenolates
AU2003286352A1 (en) Process for the preparation of fexofenadine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150612